Wolverine Trading, LLC Durect Corp Call Options Transaction History

Wolverine Trading, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $46,890 - $68,251	-52,100 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.21 - $1.61 $23,353 - $31,073	-19,300 Reduced 27.03%	52,100 $67,000
Q2 2021 Aug 06, 2021	BUY	$1.6 - $2.02 $49,440 - $62,418	30,900 Added 76.3%	71,400 $121,000
Q1 2021 May 14, 2021	BUY	$1.86 - $2.87 $29,574 - $45,633	15,900 Added 64.63%	40,500 $77,000
Q4 2020 Feb 12, 2021	BUY	$1.65 - $2.43 $21,120 - $31,104	12,800 Added 108.47%	24,600 $53,000
Q3 2020 Nov 13, 2020	SELL	$1.6 - $2.35 $16,000 - $23,500	-10,000 Reduced 45.87%	11,800 $21,000
Q2 2020 Aug 13, 2020	SELL	$1.33 - $2.76 $15,428 - $32,015	-11,600 Reduced 34.73%	21,800 $55,000
Q1 2020 May 11, 2020	BUY	$0.97 - $2.85 $22,698 - $66,690	23,400 Added 234.0%	33,400 $50,000
Q4 2019 Feb 12, 2020	BUY	$1.69 - $3.8 $16,900 - $38,000	10,000 New	10,000 $35,000
Q3 2018 Nov 14, 2018	SELL	$1.06 - $1.69 $30,210 - $48,165	-28,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$0.91 - $2.24 $25,935 - $63,840	28,500 New	28,500 $61,000
Q4 2017 Feb 14, 2018	SELL	$0.78 - $2.1 $12,168 - $32,760	-15,600 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$1.55 - $1.82 $24,180 - $28,392	15,600	15,600 $28,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $230M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.